[Safety evaluation of tissue engineered medical devices using normal human mesenchymal stem cells]
- PMID: 17473528
- DOI: 10.1248/yakushi.127.851
[Safety evaluation of tissue engineered medical devices using normal human mesenchymal stem cells]
Abstract
Several recent studies demonstrated the potential of bioengineering using somatic stem cells in regenerative medicine. Adult human mesenchymal stem cells (hMSCs) derived from bone marrow have the pluripotency to differentiate into cells of mesodermal origin, e.g., bone, cartilage, adipose, and muscle cells; they, therefore, have many potential clinical applications. On the other hand, stem cells possess a self-renewal capability similar to cancer cells. For safety evaluation of tissue engineered medical devices using normal hMSCs, in this study, we investigated the expression levels of several genes that affect cell proliferation in hMSCs during in vitro culture. We focused on the relationship between the hMSC proliferation and their transforming growth factor beta (TGFbeta) signaling during in vitro culture. The proliferation rate of hMSCs gradually decreased and cellular senescence was observed for about 3 months. The mRNA expressions of TGFbeta1, TGFbeta2, and TGFbeta receptor type I (TGFbetaRI) in hMSCs increased with the length of cell culture. The mRNA expressions of Smad3 increased, but those of c-myc and nucleostemin decreased with the length hMSCs were in in vitro culture. In addition, the expression profiles of the genes which regulate cellular proliferation in hMSCs were significantly different from those of cancer cells. In conclusion, hMSCs derived from bone marrow seldom underwent spontaneous transformation during 1-2 months in vitro culture for use in clinical applications. In hMSCs as well as in epithelial cells, growth might be controlled by the TGFbeta family signaling.
Similar articles
-
Changes in expression of genes related to cell proliferation in human mesenchymal stem cells during in vitro culture in comparison with cancer cells.J Artif Organs. 2006;9(3):179-84. doi: 10.1007/s10047-006-0338-z. J Artif Organs. 2006. PMID: 16998703
-
Activin Receptor-Like Kinase Receptors ALK5 and ALK1 Are Both Required for TGFβ-Induced Chondrogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells.PLoS One. 2015 Dec 31;10(12):e0146124. doi: 10.1371/journal.pone.0146124. eCollection 2015. PLoS One. 2015. PMID: 26720610 Free PMC article.
-
Regulation of mesenchymal stem cell chondrogenesis by glucose through protein kinase C/transforming growth factor signaling.Osteoarthritis Cartilage. 2013 Feb;21(2):368-76. doi: 10.1016/j.joca.2012.11.001. Epub 2012 Nov 11. Osteoarthritis Cartilage. 2013. PMID: 23151458
-
Bone morphogenetic proteins.Growth Factors. 2004 Dec;22(4):233-41. doi: 10.1080/08977190412331279890. Growth Factors. 2004. PMID: 15621726 Review.
-
Comparative review of growth factors for induction of three-dimensional in vitro chondrogenesis in human mesenchymal stem cells isolated from bone marrow and adipose tissue.Tissue Eng Part B Rev. 2010 Aug;16(4):435-44. doi: 10.1089/ten.TEB.2009.0705. Tissue Eng Part B Rev. 2010. PMID: 20196646 Review.
Cited by
-
Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds.Annu Rev Biomed Eng. 2011 Aug 15;13:27-53. doi: 10.1146/annurev-bioeng-071910-124743. Annu Rev Biomed Eng. 2011. PMID: 21417722 Free PMC article. Review.
